ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1504	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1029	Wait till PSS sees the bioshield that Trump uses on him. Sad, but it's the w	galt	1	5/13/2025
1028	Galt: He might be playing politics :) x.com	luckydog88	2	5/13/2025
1027	urotoday.com	mannamal	2	5/13/2025
1026		mannamal	-	5/13/2025
1025	one more analyst rec popped up: HC Wainwright & Co. analyst Andres Maldonad	luckydog88	1	5/12/2025
1024	knew this was coming again :) D. Boral Capital analyst Jason Kolbert maintains	luckydog88	1	5/12/2025
1023	CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX) , a leading immu	luckydog88	-	5/12/2025
1022	Another class action suit is surely coming, imo. Hope PSS is not playing politi	galt	-	5/10/2025
1021	If this in fact what happened, it’s what I have been afraid of (in broad outline	Olecranon	-	5/10/2025
1020	Thanks for that info. I would add though that based on PSS's actions/commen	luckydog88	1	5/10/2025
1019	IBRX apparantly received encouragement in January that the unmet need in BCG unr	End2War	1	5/10/2025
1018	Understand what you meant now, thanks.	CCS648	-	5/7/2025
1017	Avoro Capital.. Google them or go to their website. They invest in biotech solu	galt	1	5/7/2025
1016	Avoro?	CCS648	-	5/7/2025
1015	Like many here have said, this is acting very much like IMMU and has given many	galt	5	5/7/2025
1014	de-ja vu...........reminds me of the time idahoranch talked of adding under 2$ I	urslor	3	5/7/2025
1013	This is going to be the confirmatory trail for NSCLC. It recently updated to rec	mannamal	3	5/6/2025
1012	clinicaltrials.gov	mannamal	3	5/6/2025
1011	Press releases are typically drafted by Comms or Marketing departments and roll	TinfoilHat	3	5/6/2025
1010	My only quibble with your observation of the perhaps intentional obfuscation via	jargonweary	-	5/6/2025
1009	Having held IMMU for many years and endured similar disappointments I would just	jargonweary	7	5/6/2025
1008	The press release reads to me like a CYA from management/PSS to the new investor	Maturin	2	5/6/2025
1007	I did not hold IMMU, but I’ve seen so many references - it has given me a little	CCS648	1	5/6/2025
1006	"But if that’s your perception of the intent (obfuscation), why are you an	Fitzhughlaw	4	5/6/2025
1005	Happily, I did not do corporate defense work, nor is that the focus of my positi	CCS648	-	5/6/2025

Go to reply# or date (mm/dd/yy):